The first of its kind on the African continent
The first Biobank for rare metabolic diseases on the African continent was established in 2019. The Biobank stores and provides access to biological samples and clinical data from patients with rare metabolic diseases, which will help researchers to develop new diagnostic tests and treatments for these conditions.
This Biobank for rare metabolic diseases is intended to be a national asset and has already attracted national and international interest – with several research projects already registered. The growing interest in the Biobank for rare metabolic diseases will continue to create more opportunities for students and healthcare innovators alike.
The operational structures of CHM/NMP are designed to establish new collaborations as is evident from our portfolio of both national and international conference contributions. Our goal is to provide a unique resource that will help facilitate important discoveries in the field of rare metabolic diseases.
We care about every rare disease patient that is part of our biobank family. We strive to connect each patients with support groups and actively search for clinicial trials or new treatments that may be of value. If you would like to support the Biobank, do not hesitate to contact us